COS-7 cells (purple) harboring LIPA-α-syn aggregates (red) are capable to bind early endosomes (green)

(Confocal Microscope Carl Zeiss LSM 800)

ORAL PRESENTATIONS













POSTER PRESENTATIONS


 






Interplay between the endolysosomal system and protein aggregation in the pathogenesis of Parkinson’s disease - Teixeira M., Bérard M., Sheta R., St-Pierre MK., Tremblay ME., Vallières L., Oueslati A.




Development of a novel optogenetic based model of alpha-synuclein aggregation to study Parkinson’s Disease - Sheta R., Bérard M., Teixeira M., Idi W., Turmel R., Lamontagne J., Soulet D., Cicchetti D., Fon EA, Abid Oueslati.



Development of a novel optogenetic based model of alpha-synuclein aggregation to study Parkinson’s Disease - Sheta R., Bérard M., Teixeira M., Idi W., Turmel R., Lamontagne J., Soulet D., Cicchetti D., Fon EA, Oueslati A.




Optogenetic-mediated spatiotemporal control of α-synuclein aggregation mimics authentic Lewy body formation and triggers neurodegeneration - Bérard M., Sheta R., Malvaut S., Rodriguez-Aller R., Teixeira M., Turmel R., Alpaugh M., Dubois M., Dahmene M., Sales C., Lamontagne-Proulx J., St-Pierre MK., Tavassoly O., Luo W., Qazi R., Jeong JW., Durcan TM., Vallières L., Tremblay ME., Soulet D., Lévesque M., Cicchetti F., Fon EA., Saghatelyan A., Oueslati A.


Impact of alpha-synuclein aggregation on protein degradation systems and its implication in Parkinson’s Disease pathogenesis - Idi W., Teixeira M., Bérard M., Sheta R., Oueslati A.  




Impact of alpha-synuclein aggregation on protein degradation systems and its implication in Parkinson’s Disease pathogenesis - Idi W., Bérard M., Sheta R., Teixeira M., Oueslati A.